| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10048740 | HBV | ENSG00000138061.13 | protein_coding | CYP1B1 | No | No | 1545 | Q16678 Q53TK1 |
| TVIS20045685 | HPV | ENSG00000138061.13 | protein_coding | CYP1B1 | No | No | 1545 | Q16678 Q53TK1 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CYP1B1 |
|---|---|
| DrugBank ID | DB09061 |
| Drug Name | Cannabidiol |
| Target ID | BE0001111 |
| UniProt ID | Q16678 |
| Regulation Type | inhibitor |
| PubMed IDs | 26264914; 24160757 |
| Citations | Ibeas Bih C, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ: Molecular Targets of Cannabidiol in Neurological Disorders. Neurotherapeutics. 2015 Oct;12(4):699-730. doi: 10.1007/s13311-015-0377-3.@@Stout SM, Cimino NM: Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metab Rev. 2014 Feb;46(1):86-95. doi: 10.3109/03602532.2013.849268. Epub 2013 Oct 25. |
| Groups | Approved; Investigational |
| Direct Classification | Aromatic monoterpenoids |
| SMILES | CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL190461 |
